Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100

Quest Diagnostics Incorporated (DGX) Shares outstanding

Alert me on Shares outstanding

Quest Diagnostics Incorporated's shares outstanding at the end of fiscal 2025 was $113.0M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $112.0M. Over the past ten years it has ranged from $113.0M (fiscal 2025) to $145.0M (fiscal 2015) — the current reading is the lowest in ten years. Quest Diagnostics Incorporated ranks 14th of 52 Diagnostics & Research companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $113.0M 0.00%
FY2024 $113.0M 0.00%
FY2023 $113.0M (4.24%)
FY2022 $118.0M (7.81%)
FY2021 $128.0M (5.88%)
FY2020 $136.0M 0.00%
FY2019 $136.0M (2.16%)
FY2018 $139.0M (0.71%)
FY2017 $140.0M (1.41%)
FY2016 $142.0M (2.07%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $112.0M 0.00%
Mar 2026 $112.0M (0.88%)
Dec 2025 $113.0M 0.00%
Sep 2025 $113.0M 0.00%
42 more quarters

Against its own ten years

Low $113.0M High $145.0M
Ten-year median $136.0M
Current reading's percentile 27

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on DGX